These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24439166)

  • 21. Binge eating and fast cognitive worsening in an early-onset bvFTD patient carrying C9ORF72 expansion.
    Talarico G; Canevelli M; Tosto G; Piscopo P; Confaloni A; Galimberti D; Fenoglio C; Scarpini E; Gasparini M; Bruno G
    Neurocase; 2015; 21(5):543-7. PubMed ID: 25158292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis.
    Ciura S; Lattante S; Le Ber I; Latouche M; Tostivint H; Brice A; Kabashi E
    Ann Neurol; 2013 Aug; 74(2):180-7. PubMed ID: 23720273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease.
    Rollinson S; Halliwell N; Young K; Callister JB; Toulson G; Gibbons L; Davidson YS; Robinson AC; Gerhard A; Richardson A; Neary D; Snowden J; Mann DM; Pickering-Brown SM
    Neurobiol Aging; 2012 Aug; 33(8):1846.e5-6. PubMed ID: 22410647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C9ORF72: grabbing a tiger by the tail.
    Mann D
    Acta Neuropathol; 2014 Mar; 127(3):311-8. PubMed ID: 24493409
    [No Abstract]   [Full Text] [Related]  

  • 25. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
    Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
    J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Daoud H; Suhail H; Sabbagh M; Belzil V; Szuto A; Dionne-Laporte A; Khoris J; Camu W; Salachas F; Meininger V; Mathieu J; Strong M; Dion PA; Rouleau GA
    Arch Neurol; 2012 Sep; 69(9):1159-63. PubMed ID: 22964911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion.
    Englund E; Gustafson L; Passant U; Majounie E; Renton AE; Traynor BJ; Rohrer JD; Mok K; Hardy J
    Neurobiol Aging; 2012 Aug; 33(8):1850.e13-6. PubMed ID: 22483864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.
    Wallon D; Rovelet-Lecrux A; Deramecourt V; Pariente J; Auriacombe S; Le Ber I; Schraen S; Pasquier F; Campion D; Hannequin D
    J Alzheimers Dis; 2012; 32(1):19-22. PubMed ID: 22766732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontotemporal lobar degeneration: current knowledge and future challenges.
    Cerami C; Scarpini E; Cappa SF; Galimberti D
    J Neurol; 2012 Nov; 259(11):2278-86. PubMed ID: 22532172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers.
    Katisko K; Solje E; Koivisto AM; Krüger J; Kinnunen T; Hartikainen P; Helisalmi S; Korhonen V; Herukka SK; Haapasalo A; Remes AM
    J Neuroimmunol; 2018 Aug; 321():29-35. PubMed ID: 29957385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.
    Katisko K; Solje E; Korhonen P; Jääskeläinen O; Loppi S; Hartikainen P; Koivisto AM; Kontkanen A; Korhonen VE; Helisalmi S; Malm T; Herukka SK; Remes AM; Haapasalo A
    J Neurol; 2020 Jan; 267(1):76-86. PubMed ID: 31559531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.
    Lindquist SG; Duno M; Batbayli M; Puschmann A; Braendgaard H; Mardosiene S; Svenstrup K; Pinborg LH; Vestergaard K; Hjermind LE; Stokholm J; Andersen BB; Johannsen P; Nielsen JE
    Clin Genet; 2013 Mar; 83(3):279-83. PubMed ID: 22650353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refining the clinical presentation of the C9ORF72 hexanucleotide repeat expansion.
    Miller BL
    Biol Psychiatry; 2013 Sep; 74(5):320. PubMed ID: 23932343
    [No Abstract]   [Full Text] [Related]  

  • 34. Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases.
    Hübers A; Marroquin N; Schmoll B; Vielhaber S; Just M; Mayer B; Högel J; Dorst J; Mertens T; Just W; Aulitzky A; Wais V; Ludolph AC; Kubisch C; Weishaupt JH; Volk AE
    Neurobiol Aging; 2014 May; 35(5):1214.e1-6. PubMed ID: 24378086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.
    van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Theuns J; Engelborghs S; Philtjens S; Vandenbulcke M; Sleegers K; Sieben A; Bäumer V; Maes G; Corsmit E; Borroni B; Padovani A; Archetti S; Perneczky R; Diehl-Schmid J; de Mendonça A; Miltenberger-Miltenyi G; Pereira S; Pimentel J; Nacmias B; Bagnoli S; Sorbi S; Graff C; Chiang HH; Westerlund M; Sanchez-Valle R; Llado A; Gelpi E; Santana I; Almeida MR; Santiago B; Frisoni G; Zanetti O; Bonvicini C; Synofzik M; Maetzler W; Vom Hagen JM; Schöls L; Heneka MT; Jessen F; Matej R; Parobkova E; Kovacs GG; Ströbel T; Sarafov S; Tournev I; Jordanova A; Danek A; Arzberger T; Fabrizi GM; Testi S; Salmon E; Santens P; Martin JJ; Cras P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Theuns J; Philtjens S; Sleegers K; Bäumer V; Maes G; Corsmit E; Cruts M; Van Broeckhoven C; van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Philtjens S; Theuns J; Sleegers K; Bäumer V; Maes G; Cruts M; Van Broeckhoven C; Engelborghs S; De Deyn PP; Cras P; Engelborghs S; De Deyn PP; Vandenbulcke M; Vandenbulcke M; Borroni B; Padovani A; Archetti S; Perneczky R; Diehl-Schmid J; Synofzik M; Maetzler W; Müller Vom Hagen J; Schöls L; Synofzik M; Maetzler W; Müller Vom Hagen J; Schöls L; Heneka MT; Jessen F; Ramirez A; Kurzwelly D; Sachtleben C; Mairer W; de Mendonça A; Miltenberger-Miltenyi G; Pereira S; Firmo C; Pimentel J; Sanchez-Valle R; Llado A; Antonell A; Molinuevo J; Gelpi E; Graff C; Chiang HH; Westerlund M; Graff C; Kinhult Ståhlbom A; Thonberg H; Nennesmo I; Börjesson-Hanson A; Nacmias B; Bagnoli S; Sorbi S; Bessi V; Piaceri I; Santana I; Santiago B; Santana I; Helena Ribeiro M; Rosário Almeida M; Oliveira C; Massano J; Garret C; Pires P; Frisoni G; Zanetti O; Bonvicini C; Sarafov S; Tournev I; Jordanova A; Tournev I; Kovacs GG; Ströbel T; Heneka MT; Jessen F; Ramirez A; Kurzwelly D; Sachtleben C; Mairer W; Jessen F; Matej R; Parobkova E; Danel A; Arzberger T; Maria Fabrizi G; Testi S; Ferrari S; Cavallaro T; Salmon E; Santens P; Cras P;
    Hum Mutat; 2013 Feb; 34(2):363-73. PubMed ID: 23111906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration.
    Katisko K; Haapasalo A; Koivisto A; Krüger J; Hartikainen P; Korhonen V; Helisalmi S; Herukka SK; Remes AM; Solje E
    J Alzheimers Dis; 2018; 62(2):789-794. PubMed ID: 29480183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teenage-onset progressive myoclonic epilepsy due to a familial
    van den Ameele J; Jedlickova I; Pristoupilova A; Sieben A; Van Mossevelde S; Ceuterick-de Groote C; Hůlková H; Matej R; Meurs A; Van Broeckhoven C; Berkovic SF; Santens P; Kmoch S; Dermaut B
    Neurology; 2018 Feb; 90(8):e658-e663. PubMed ID: 29352102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes.
    Hokelekli FO; Whitwell JL; Machulda MM; Jones DT; Uitti RJ; Pham NTT; Giannini C; Baker M; Lowe VJ; Dickson DW; Josephs KA
    Neurocase; 2021 Apr; 27(2):212-222. PubMed ID: 33904372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases.
    Souza PV; Pinto WB; Oliveira AS
    Arq Neuropsiquiatr; 2015 Mar; 73(3):246-56. PubMed ID: 25807132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of dipeptide-repeat protein pathology in C9orf72 mutation cases.
    Mackenzie IR
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):217-9. PubMed ID: 26577056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.